Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


01st week of 2022 patent applcation highlights part 8
Patent application numberTitlePublished
20220000701ASSIST DEVICE - An assist device includes a first body-worn unit; second body-worn units; an actuator; a controller configured to obtain an assist parameter that determines assist torque to be generated, and perform control to operate the actuator at an output based on the assist parameter; and a tilt angle detection part configured to obtain tilt angle information on a tilt angle of an upper body of a user. The actuator includes arms; and swing angle detection parts configured to obtain swing angle information on swing angles of the arms that represent angles formed by the upper body and thighs of the user. The controller is configured to obtain the assist parameter based on the swing angle information and the tilt angle information.2022-01-06
20220000702Pneumatic distributor and walking aid system including the same - Provided is a pneumatic distributor for intaking and exhausting air of an air pad, including a lower plate member having one side to which an intake port and an exhaust port are connected and the other side to which a first port and a second port connected to the air pad are connected, and an upper plate member rotatably coupled to an upper surface of the lower plate member and configured to relatively rotate to control intaking and exhausting air through the first port and the second port, wherein the lower plate member includes an intake recess communicating with the intake port, an exhaust recess communicating with the exhaust port, a first recess communicating with the first port, and a second recess communicating with the second port, and the intake recess, the exhaust recess, the first recess, and the second recess are formed on an upper surface of the lower plate member.2022-01-06
20220000703OPTIMIZED ANKLE EXOSKELETON FOOT PLATE FUNCTION AND GEOMETRY - A foot plate for an assistive device is disclosed. The foot plate includes a planar vertical mounting portion on its lateral side, and a planar foot bed. The foot plate includes a gradual shoulder portion, such as a web of material that ties the vertical mounting portion to the foot bed. The foot plate also includes a heel cup at a posterior end for engaging the heel of a user. The foot plate also includes a rocker portion underneath the toes of a user, on an anterior end of the foot plate. The rocker portion enables the toes to flex in the dorsal direction during walking without the foot becoming disengaged from the foot plate.2022-01-06
20220000704SELF CONTAINED POWERED EXOSKELETON FOR A DISABLED USER - A walker for use by a mobility impaired disabled user. The walker supports the user while moving them through a set of movements correlating to a walking motion. The walker includes an exoskeleton, a power source in the form of a battery pack or other similar onboard power pack together with its associated power supply cables, and a control system2022-01-06
20220000705COMPRESSION GARMENT COMPLIANCE - Determining whether a compression garment is worn by a wearer of the garment by analyzing a pressure signal waveform indicative of a fluid pressure in an inflatable and deflatable bladder of the compression garment. Variance detected in the pressure signal waveform during the analysis is indicative of a change in condition of the compression garment. In one aspect the change in condition is verified using confirmatory analysis. In another aspect, the variance is one of a pressure rise and a pressure impulse. In yet another aspect, the variance is an oscillating amplitude as a function of time representative of a pulse of the wearer.2022-01-06
20220000706PORTABLE MASSAGE DEVICE WITH KNEADING MASSAGE AND PERCUSSION MASSAGE FUNCTION - The invention relates to a portable massage device with a sheath, having a variable-shape contact segment for resting on a body region to be massaged, a rotating massage head and a pummeling massage head, the rotating massage head and the pummeling massage head being arranged within the sheath and being set up to cause a change of shape of the contact segment during operation.2022-01-06
20220000707SKIN CARE DEVICE - Discussed is a skin care device comprising: a main body having a processor, and an ultrasonic vibrator assembly disposed on one end of the main body and forming a contact surface with a skin of a user, wherein the processor controls the ultrasonic vibrator assembly to apply an ultrasonic vibration to the skin according to at least one of a frequency characteristic, an output characteristic, and a duty ratio characteristic for removing wastes on a surface of the skin.2022-01-06
20220000708BOTH SIDES UTILIZED BALL - Disclosed herein is a both sides utilized (BOSU) ball. The BOSU ball includes a main body and a vibration assembly. The main body is elastic, and the main body is capable of deforming when subjected to an external force and returning to an original shape when the external force is removed. The main body is configured to interact with a user to assist the user to exercise. The vibration assembly is connected to the main body, and the vibration assembly is configured to vibrate the main body to relax the user.2022-01-06
20220000709System for Assisting Rescuers in Performing Cardio-Pulmonary Resuscitation (CPR) on a Patient - A system for assisting a rescuer in performing cardio-pulmonary resuscitation (CPR) on a patient includes: a proximity sensor configured to be positioned at a location corresponding to a location of a rescuer's hand when delivering compressions to a patient's chest, the proximity sensor configured to produce a signal indicative of the rescuer's hands being released from the patient's chest; a medical device operatively coupled with the proximity sensor and configured to provide resuscitative treatment to the patient; and a controller communicatively coupled with the medical device and the proximity sensor. The controller is configured to: determine, based upon the signal from the proximity sensor, if the rescuer's hands have been released from the patient's chest, and trigger an action by the medical device in response to a determination that the rescuer's hands have been released from the patient's chest.2022-01-06
20220000710PEDICURE CHAIRS AND PUMPS FOR USE WITH PEDICURE CHAIRS AND RELATED METHODS - A jet pump has an impeller with a magnet that can be rotated by a shaft having a magnetic drive plate and wherein the impeller and the magnetic drive plate are separated from one another by at least one solid wall surface. The impeller can be located in a pump housing having a base and a cover. The base can have a surface bearing so that the impeller can contact therewith and rotated against the surface of the surface bearing.2022-01-06
20220000711ACUPRESSURE MEDALLION, METHOD AND DEVICE FOR ITS MANUFACTURE AND METHOD OF REDUCTION OF PAIN FROM ACUPRESSURE REFLEXOTHERAPY - The acupressure element includes a base with spiked applicators and an additional layer of low-melting substance, which creates a surface flush with the points of the spiked applicators. The layer hides the points and prevents pain. During a reflexotherapy procedure, the layer of low-melting material melts, either under the influence of human body heat or with the use of external heating. The points of the spiked applicators are gradually released and begin to press on the skin. The pressure on the skin does not occur immediately, allowing to prepare for increased pain later and acclimate accordingly.2022-01-06
20220000712MASSAGE ASSEMBLY, HUMAN BODY MASSAGE DEVICE, AND OPERATION METHOD THEREOF - The present disclosure relates to a massage assembly, a human body massage device and an operation method thereof. The massage assembly includes: a first massage arm; a first massage head, rotatably connected to the first massage arm to massage acupoints and skin near an anus along with a motion of the first massage arm relative to a human body; and a rotation locking structure, arranged between the first massage arm and the first massage head to adjust, lock or unlock a rotation angle of the first massage head relative to the first massage arm. According to the present disclosure, the massage mode of the acupoints near the anus can be adjusted as required, and the massage effect can be improved.2022-01-06
20220000713NEEDLE WARMING SYSTEM - A needle warming system includes: a heating tube for heating acupuncture needles; a ring-shaped rechargeable battery for supplying power to the heating tube, and a empty space for fixing the heating tube for charging The battery accepts the charging of the wireless charging unit in a wireless charging mode; a display unit is used to display the working status and charging status of the needle warming system; the control unit is used to control the temperature of the heating tube, and the charging of the rechargeable battery, and display unit. The wireless rechargeable battery avoids the external power supply and the traditional power wiring obstacles; the creation of empty space in the center with ring-shaped rechargeable batteries and heating pads, medicine pads, etc., allows acupuncture needles to enter the heating tube, which is convenient for the implementation of acupuncture warming needles technique. Moreover, the whole needle warming system is compact, small and portable.2022-01-06
20220000714METHOD FOR IMPROVING BLOOD FLOW OF THE CEREBRAL CORTEX - A method for improving blood flow of the cerebral cortex is provided in the present invention. The method for improving blood flow of the cerebral cortex includes the following steps: stimulating a predetermined site of a subject in need thereof to improve blood flow of the cerebral cortex of the subject in need thereof, wherein the predetermined site is Shousanli (LI10) acupoint.2022-01-06
20220000715MEDICATION BOTTLE WITH ANTI-TAMPERING FEATURES - A medication bottle includes an outer container wall, an inner container wall and a fluid, such as an aversive liquid, located between the walls. In another aspect, the fluid is located within separate compartments or channels located between the walls where the walls contact or are secured to each other. A further aspect provides a removeable cap including multiple sensors, at least one of which is a biometric sensor.2022-01-06
20220000716Medicine Case for Improved Regimen Compliance - A modular smart packaging case comprising reversibly attachable electronics and detection modules is disclosed. The detection module includes a sensor array for monitoring the state of a blister pack containing a plurality of product units. The electronics module contains the high-value electronics required to read the sensors of the array, process the sensor output, and enable communications to and from the case. The electronics module and detection module are operatively coupled via a universal interface that enables the same electronics module to operate with a plurality of detection modules of different configurations. In some embodiments, the electronics module operatively couples with multiple detection modules.2022-01-06
20220000717ADAPTER AND INJECTION FLUID TRANSFER METHOD - The adapter includes a housing and a filling nozzle provided in communication with a containing portion in the housing and coming into contact with an end surface of the injection device, in which the injection port of the injection nozzle is formed, when the housing is attached to the injection device. An open end of the filling nozzle is set to be smaller than an inner diameter of the containing portion and larger than the injection port. Of an internal space of the housing from a partial region of the containing portion to the open end, at least a predetermined space being continuous and including the partial region is formed in a manner where an inner diameter of the predetermined space decreases toward a side of the open end. According to this configuration, the injection fluid can be suitably transferred from the outside to a needleless injector.2022-01-06
20220000718Fluid Container Devices, Methods and Systems - A drug container assembly for use with a parenteral drug delivery device is disclosed. The container assembly includes a container configured to hold the medication and an intermediate port connector. The port connector may be fixedly coupled to the container and removably coupled to the delivery device in a convenient, reliable, and sealed manner In use, the port connector may convey the medication from the container to the delivery device for delivery to the patient.2022-01-06
20220000719PILL CUTTER - A pill cutter has a base, a clamping assembly, a connecting unit, a cover, and a cutting assembly. The clamping assembly has two first clamping units moveably mounted on the base. The connecting unit has a base end moveably mounted on the base and a cover end pivotally mounted on the cover. The cutting assembly has a pressing unit moveably mounted on the cover and a blade securely mounted on the pressing unit. When the cover is opened, the connecting unit moves along with the cover and pulls the two first clamping units away from each other. When the cover is closed, the two first clamping units move toward each other by springs to stably clamp a pill in any shape or size. Therefore, a user can simply press the pressing unit to move the blade to safely cut the clamped pill.2022-01-06
20220000720PACIFIER WITH FLUID PASSAGEWAY AND EXCHANGEABLE HOUSING - A pacifier comprising a reusable suction part and at least one exchangeable housing part which are releasably connectable to each other, wherein said suction part comprises a nipple and a shield connected to each other, wherein said suction part comprises a passageway through which a fluid can pass from outside a mouth of a user of the pacifier to inside the mouth of the user of the pacifier, and wherein said suction part comprises at least one first connection device, and wherein said housing part comprises a housing and at least one second connection device which is releasably connectable to the at least one first connection device, wherein said housing comprises at least one heat and moisture exchanger (HME) device and/or at least one filter device.2022-01-06
20220000721BIFUNCTIONAL AND POLYFUNCTIONAL COINITIATORS IN DENTAL COMPOSITIONS - A dental composition comprising 2022-01-06
20220000722HIGHLY LOADED METAL OXIDE MATERIALS BY SELF-ASSEMBLY FOR EXTENDED BIOLOGICALLY ACTIVE MOLECULE RELEASE IN MEDICAL AND DENTAL APPLICATIONS - A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.2022-01-06
20220000723CURABLE DENTAL TWO-PACK COMPOSITION - The present invention is related to a curable dental two-pack composition comprising: 2022-01-06
20220000724Coating Compositions - A coating product comprising an aqueous chromic composition comprising a colour-change component, such as a liquid crystal and a polymer binder dispersed in an aqueous solution. The coating product also contains a colourant which may be dispersed or dissolved in the aqueous composition is provided as a separate aqueous solution comprising the colourant to provide an underlying layer.2022-01-06
20220000725METHOD FOR PRODUCING COATING FILM - Provided is a method for producing a coating film on the skin by electrostatic spraying, the coating film having excellent appearance and excellent scratch resistance and stretch resistance.2022-01-06
20220000726FOAMING MIXED ALCOHOL/WATER COMPOSITIONS COMPRISING A STRUCTURED ALKOXYLATED SILOXANE - The disclosure includes structured siloxanes which can foam in low surface tension solutions. The foaming compositions may form foam in alcohol/water and hydrocarbon condensates. The foaming compositions may replace surfactants in other compositions. The disclosure also includes sterilizing alcohol compositions, cleaning compositions, such as hard surface cleaners, warewash detergents, rinse aids, hand sanitizers, and the like which incorporate the same.2022-01-06
20220000727ORGANIC AND MINERAL FILTER HYBRID SUNSCREEN - A sunscreen composition provided as a water-in-oil emulsion of aqueous and oil phases includes a combination of organic and mineral UV filters, and one or a combination of, each, of dispersing agents, film formers, emulsifiers, structuring agents, and aqueous and oil phase solvents. The sunscreen composition confers water-resistant broad-spectrum UV protection, is non-whitening, and demonstrates acceptable sensorial properties, and stability through a range of temperatures.2022-01-06
20220000728Cosmetic Composition For Sustaining Luster - The present disclosure relates to a gloss-sustainable cosmetic composition, which improves a stuffy feel of use, while including a high-refractive index oil, and provides improved skin gloss sustainability. The water-in-oil type cosmetic composition shows a reduced stuffy feel of use caused by high-refractive index oil, and provides significantly high initial gloss and gloss sustainability.2022-01-06
20220000729METHOD FOR TREATING HAIR, COMPRISING THE APPLICATION OF COATED PIGMENTS AND SILANES - A process for dyeing keratinous material, in particular human hair, comprising 2022-01-06
20220000730CLAY MASK COMPOSITION AND METHOD FOR USING THE SAME - A cosmetic clay mask composition is described. The clay mask composition has bentonite, oil, water, kaolin and thickener. The composition is surprisingly stable without having surfactant and does not impart a dry sensation after use.2022-01-06
20220000731ZINC OXIDE PARTICLES, PHOTOSTABLE UV FILTERS, AND METHODS OF USE THEREOF - Zinc oxide particles are prepared as a dry powder through a vapor phase formed by a plasma process, or by introducing defects into stoichiometric zinc oxide particles in a liquid carrier through mechanical stress. The zinc oxide has an O:Zn ratio of at least 0.99, an average particle size of 10 to 300 nm, and a sufficient concentration of oxygen vacancies and zinc vacancies to give a dispersion of the particles in C12-C15 alkyl benzoate an orange to tan color corresponding to a ΔE value of at least 15 in a Dispersion Color Test. The particles contain no aggregates and have no detectable particles 500 nm or larger, on a number-weighted basis2022-01-06
20220000732Mineral Sunscreen Compositions - The disclosure relates to a mineral sunscreen composition having a synergistic combination of a mineral sunscreen agent and a film former. The mineral sunscreen agent may include titanium dioxide, zinc oxide, or combinations thereof. The film former may be selected from polyester copolymers. For example, the polyester copolymers may include octyldodecyl citrate crosspolymer. The mineral sunscreen composition may further include a non-aqueous diluent. The non-aqueous diluent may include a hydrocarbon. The sunscreen composition may be in the form of a lotion, a spray, or combinations thereof.2022-01-06
20220000733ALCOHOL-BASED SANITIZER FORMULATION FOR TOPICAL APPLICATION - Disclosed is are methods and compositions capable of sanitizing and hydrating skin. The compositions can include alcohol, glycerin, betaine, PEG-50 shea butter, butylene glycol, and 2022-01-06
20220000734COMPOSITION AND METHOD OF STRENGTHENING SKIN BARRIER - Provided are a composition including a compound of the following chemical formula as an active ingredient and a method of strengthening the skin barrier by applying it to skin of a subject:2022-01-06
20220000735ANTI-ACNE COMPOSITION - A composition for treating acne includes an anti-acne active agent that includes salicylic acid, an emulsifier, an emollient, particles of zinc oxide, water and a humectant. The composition has a sun protection factor (SPF) of at least 5. The zinc oxide can be included in a powder with particles that are formed as aggregates of smaller particles which, when used in a dispersion at a concentration of 50 weight % of zinc oxide, produces a transparent composition.2022-01-06
20220000736HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION - A composition comprising (i) 0.01 to 10 wt % of a linear, cationic conditioning surfactant; (ii) 0.1 to 10 wt % of a linear fatty material; (iii) a particulate benefit agent; (iv) 0.01 to 5 wt %, at 100% active, of a branched cationic co-surfactant, selected from structure (1) wherein: ⋅R2022-01-06
20220000737COMPOSITION COMPRISING AT LEAST TWO ANIONIC SURFACTANTS, A NONIONIC SURFACTANT, AN AMPHOTERIC SURFACTANT, AND AT LEAST ONE DIRECT DYE - Composition comprising at least two anionic surfactants, a nonionic surfactant, an amphoteric surfactant, and at least one direct dye The present invention relates to a composition for the cosmetic treatment of keratin fibres, in particular of the hair, comprising at least two anionic surfactants, at least one nonionic surfactant, at least one amphoteric surfactant and at least one direct dye. The invention also relates to a cosmetic process for treating keratin fibres, especially for dyeing the hair, using such a composition, and also to a use of said composition.2022-01-06
20220000738ORAL COMPOSITIONS - A chewable composition for teeth-whitening comprising a first region and a second region separated by a barrier layer; the first region comprising carbamide peroxide having water content of about 2% or less, a wetting agent (e.g., glycerin), an anhydrous chewing gum base having water content of about 1% or less, an anhydrous fruit acid, and one or more gum additives; and the second region comprising a chewable composition comprising a gum base, a source of bicarbonate ion, and one or more gum additives. A kit comprising separate chewable compositions corresponding to the first and second regions, and methods for whitening teeth using the chewable composition are also provided.2022-01-06
20220000739ORAL COMPOSITIONS - A chewable composition for teeth-whitening comprising a first region and a second region separated by a barrier layer; the first region comprising carbamide peroxide having water content of about 2% or less, a wetting agent (e.g., glycerin), an anhydrous chewing gum base having water content of about 1% or less, an anhydrous fruit acid, and one or more gum additives; and the second region comprising a chewable composition comprising a gum base, a source of bicarbonate ion, and one or more gum additives. A kit comprising separate chewable compositions corresponding to the first and second regions, and methods for whitening teeth using the chewable composition are also provided.2022-01-06
20220000740Personal Care Compositions - A personal care composition comprising a surfactant system consisting essentially of an anionic surfactant and a zwitterionic surfactant; a preservative; a pH modifier; and a rheology modifier, wherein the ratio of anionic surfactant to zwitterionic surfactant is about 1:1 to about 2.2:1 of the total composition by weight.2022-01-06
20220000741RED COLORANT FREE OF COCHINEAL RED AND COMPOSITIONS COMPRISING THE SAME - Colorant Compositions free of cochineal red are described. The colorant compositions mimic the color of cochineal red and they are stable in the pressure of active materials typically found in cosmetic compositions.2022-01-06
20220000742COSMETIC COMPOSITION COMPRISING THEASINENSIN A - A composition contains, as an effective component, theasinensin A, an enantiomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof. The composition has an excellent stability and provides wrinkle-reducing or skin elasticity-enhancing benefits, and skin-brightening benefits by containing theasinensin A, an enantiomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof, as an effective component.2022-01-06
20220000743SURFACTANT-CONTAINING COSMETIC PRODUCT COMBINED WITH BIS(TRIETHOXYSILYLPROPYL)AMINE, FOR CLEANING AND CARE OF HUMAN HAIR - The present disclosure relates to a cosmetic composition for treating a keratinous material, comprising a) at least one organic silicon compound and b) an anionic, nonionic and/or amphoteric surfactant capable of caring for stressed hair.2022-01-06
20220000744ORGANIC SILICON COMPOUNDS IN ANHYDROUS PHASE FOR INCREASING THEIR STORAGE STABILITY - The present disclosure relates to an anhydrous carrier medium for increasing the storage stabilization of organic silicon compounds comprising at least one organic silicon compound, at least one branched or linear C8-C30 alkane, at least one branched or linear C10-C30 fatty alcohol, and at least one branched or linear C2-C8 monohydric alcohol. The present disclosure further relates to the use of the anhydrous carrier medium for the production of cosmetic compositions.2022-01-06
20220000745ACTIVE SUBSTANCE COMPOSITION FOR CHANGING THE SHAPE OF HAIR - The present disclosure relates to an active ingredient composition for the care and surface modification of human hair. In particular, the present disclosure relates to a cosmetic composition for treating a keratinous material comprising a) at least one organic silicon compound and b) a firming copolymer composed of at least the monomer units N-tert-octylacrylamide, acrylic acid and tert-butylaminoethyl methacrylate.2022-01-06
20220000746BIS(TRIETHOXYSILYLPROPYL)AMINE COMBINED WITH AN ALKANE - The present disclosure relates to an active ingredient composition for care and surface modification of human hair: The present disclosure especially relates to a cosmetic product for the treatment of a keratinous material, comprising 1) at least one organic silicon compound and b) at least one branched or linear C8 to C30 alkane, wherein the cosmetic product is suitable to nourish damaged hair.2022-01-06
20220000747BIS(TRIETHOXYSILYLPROPYL)AMINES COMBINED WITH AN ACID - The present disclosure relates to an active ingredient composition for care of human hair: In particular, the present disclosure relates to a cosmetic product for the treatment of a keratinous material, comprising a) at least one organic silicon compound and b) an organic and/or inorganic acid with a pKS value from about −6 to about 5, wherein the cosmetic product is particularly suitable for care, temporary shaping and protection of hair.2022-01-06
20220000748BIS(TRIETHOXYSILYLPROPYL)AMINES IN COMBINATION WITH A THICKENING AGENT - The present disclosure relates to an active ingredient composition for shape change and surface modification of human hair. In particular, the present disclosure relates to a cosmetic agent for treating a keratinous material comprising a) at least one organic silicon compound and b) at least one thickener, the cosmetic agent being particularly suitable for treating colored hair.2022-01-06
20220000749METHOD FOR TREATING HAIR, COMPRISING THE APPLICATION OF A FIRST AGENT (A) HAVING A SILANE AND A CHROMOPHORIC COMPOUND, AND A SECOND AGENT (B) HAVING A FILM-FORMING POLYMER - The subject of the present disclosure is a process for dyeing keratinous material, in particular human hair, comprising the following steps: 2022-01-06
20220000750THE PROCESS FOR THE PREPARATION AND USE OF HAIR TREATMENT COMPOSITIONS CONTAINING ORGANIC C1-C6 ALKOXY SILANES - The subject of the present application is a method for the preparation and use of an agent for the treatment of keratinous material, in particular human hair, comprising the following steps: 2022-01-06
20220000751METHOD FOR PREPARING AND USING HAIR TREATMENT AGENTS WITH ORGANIC C1-C6-ALKOXY-SILANES - The subject of the present application is a process for the preparation of an agent for the treatment of keratinous material, in particular human hair, comprising the following steps: 2022-01-06
20220000752HYALURONIC ACID COMPOSITION - An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G′ of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and to a method of manufacturing such a composition.2022-01-06
20220000753SULFATE-FREE PERSONAL CARE COMPOSITIONS AND METHODS FOR USING SUCH COMPOSITIONS - The present invention relates to sulfate-free aqueous personal care composition comprising a surfactant system comprising at least one methyl oleoyl taurate, one isethionate and one alkoxylated sulfosuccinate, and from about 0.2 pbw to about 15 pbw of a conditioning agent. It is also directed toward the use of such a composition for washing keratin substrates, in particular the hair or the scalp.2022-01-06
20220000754PERFUME GEL - The present invention relates to a fragrancing, in particular cosmetic and/or dermatological, composition, comprising:2022-01-06
20220000755Personal Care Compositions - Described herein are personal care compositions comprising a solid vinylpyrrolidone/vinyl acetate copolymer; a vinylpyrrolidone/vinyl acetate copolymer; and a cosmetically acceptable carrier. Methods of making and using the same are also described.2022-01-06
20220000756COSMETIC PRODUCT - This cosmetic product has extensibility and imparts use feels such as silkiness and smoothness, and further demonstrates excellent soft focus effects, and contains: (A) spherical organopolysiloxane particles of which 90% by mole or more are constituted from organosilsesquioxane units and which have a volume average particle size of 0.1 to 30 μm and an average refractive index of 1.44 to 1.57, and; (B) an oil agent; and one or more selected from (C) a silicone crosslinked product and (D) a silicon resin coating silicon rubber powder.2022-01-06
20220000757FOAMING MIXED ALCOHOL/WATER COMPOSITIONS COMPRISING A COMBINATION OF ALKYL SILOXANE AND A HYDROTROPE/SOLUBILIZER - The disclosure includes synergistic combinations of pendent alkyl siloxanes and PEG-modified castor oils which can form microemulsions and foam in low surface tension solutions. The foaming compositions may form foam in water, alcohol/water, and hydrocarbon condensates. The foaming compositions may replace surfactants in other compositions and forms stable emulsions or microemulsions with oils, including non-trans fats proteins, and fatty acids. The disclosure also includes sterilizing alcohol compositions, cleaning compositions, such as hard surface cleaners, warewash detergents, rinse aids and the like which incorporate the same.2022-01-06
20220000758COSMETIC - The object of the present invention is to provide a cosmetic capable of giving high SPF values while maintaining feeling on use required for oil-in-water cosmetics, such as freshness and being easy to spread and reducing burden on the skin.2022-01-06
20220000759HAIR CONDITIONING COMPOSITION - Processes treat hair with aqueous compositions comprising one or more cationic polymers having certain cationic change densities and one or more aminated silicones. The novel processes provide long lasting conditioning to the hair and improve combability and suppleness of the hair which is maintainable up to twenty subsequent hair washes.2022-01-06
20220000760COMPOSITIONS AND METHODS FOR PREVENTING, SLOWING, AND REVERSING SKIN AGING - Disclosed are methods of treating aging effects on a subject skin, comprising contacting the skin with a skin microbiome complex, including topical compositions containing YM Microbiome Complex and Advanced Probiotic Complex, methods of treatment using the compositions and methods of preparing the compositions for preventing, slowing, and reversing skin aging. Also disclosed are related formulations and methods of skin microbiome transplantation.2022-01-06
20220000761COSMETIC COMPOSITION, METHOD FOR THE PRODUCTION OF ASTROCARYUM VULGARE OIL AND/OR BUTTER, USE OF THE COSMETIC COMPOSITION AND METHOD FOR THE PRODUCTION AND/OR PROTECTION AGAINST DEGRADATION OF HYALURONIC ACID IN THE SKIN - A cosmetic composition is provided. The cosmetic composition includes 2022-01-06
20220000762COMPOSITIONS FOR TREATING OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES AND SKIN AGEING AND DIAGNOSIS OF OXIDATIVE STRESS-ASSOCIATED SKIN DISEASES - The present application relates to the use of compositions comprising a live 2022-01-06
20220000763SUBLINGUAL AND BUCCAL DOSAGE FORMS OF CANNABINOID EXTRACTS AND METHOD OF USE THEREOF - The invention relates to compositions for sublingual and/or buccal administration comprising at least one cannabinoid or cannabinoid extract, triglyceride, alcohol, and at least one surfactant.2022-01-06
20220000764STABILIZED TERPENE-ENRICHED CANNABINOID EXTRACT AND METHODS OF USE THEREOF - The invention provides a composition suitable for use in a personal vaporizer, comprising an oil soluble liquid emulsifier base and an extract, wherein the extract comprises a cannabinoid and a terpene, methods of administering such compositions to a subject, and related kits.2022-01-06
20220000765METHODS AND COMPOSITION FOR TREATING MICROBIAL INFECTIONS - Described herein are antimicrobial (e.g., antibacterial, antiviral) compositions and methods of using such compositions.2022-01-06
20220000766PARENTERAL NUTRITION CONTAINING TRACE ELEMENTS - A parenteral nutrition including at least one of an amino acid, a dextrose, a lipid, an electrolyte or a mixture thereof and a trace element including at least one of zinc, copper, selenium, or manganese is provided. The parenteral nutrition including the trace element is stable for about at least 3 days to about 14 days. Methods of preparing and using the stable injectable parenteral nutrition are also provided.2022-01-06
20220000767NASAL HYGIENE COMPOSITIONS, ANTIMICROBIAL TREATMENTS, DEVICES, AND ARTICLES FOR DELIVERY OF SAME TO THE NOSE, TRACHEA AND MAIN BRONCHI - Salt-based non-therapeutic hygienic formulations or compositions or therapeutic formulations or compositions, for example those rich in calcium, are effective against airborne pathogens, suppressing virus shedding, for instance by increasing a surface viscoealasticity of airway lining fluid. Associated apparatus, methods and articles are used to deliver salt-based non-therapeutic hygienic formulations or compositions as hygienic treatments to the upper respiratory tract. Associated apparatus, methods and articles are used to deliver salt-based therapeutic antimicrobial formulations or compositions to the upper respiratory tract. For example, nasal delivery of calcium-rich salines with aerosol droplet size of around 10 μm (e.g., 7 μm-15 μm, or more preferably 9 μm-10 μm) may advantageously limit distribution to the nose and upper airways of the respiratory tract, suppressing bioaerosol generation. A nebulizer may deliver the aerosol into free space, or into a partially enclosed volume, and the composition naturally inspired by one or more subjects.2022-01-06
20220000768POROUS PHOTONIC CRYSTALS FOR DRUG DELIVERY TO THE EYE - A minimally invasive controlled drug delivery system for delivering a particular drug or drugs to a particular location of the eye, the system including a porous film template having pores configured and dimensioned to at least partially receive at least one drug therein, and wherein the template is dimensioned to be delivered into or onto the eye.2022-01-06
20220000769VASOCONSTRICTION COMPOSITIONS AND METHODS OF USE - The invention generally relates to compositions for inducing vasoconstriction. The compositions comprise highly selective alpha-2 adrenergic receptor agonists, at low concentrations, such as below 0.05% weight by volume. The compositions preferably comprise brimonidine. The compositions preferably have pH between about 5.5 and about 6.5.2022-01-06
20220000770BUCCAL MICRO-EFFERVESCENT TABLET AND PREPARATION METHOD THEREOF - Provided is a buccal micro-effervescent tablet and preparation method thereof. The buccal micro-effervescent tablet comprises a nutrient, a sugar alcohol, an acid source, an alkali source, magnesium stearate, an essence and a sweetening agent, wherein the sugar alcohol is lactose, maltitol, sorbitol, isomaltitol, mannitol, erythritol or any combination thereof; the sweetening agent is sucralose, aspartame, stevioside, fructose, granulated sugar, mogroside or any combination thereof. The micro-effervescent tablet may cause micro effervescence reaction under the action of saliva in mouth.2022-01-06
20220000771CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS - The present disclosure relates to chewable gel products containing a gel carrier and an active pharmaceutical ingredient (API), where the chewable gel product has an acceptable taste.2022-01-06
20220000772SPECIALLY FORMULATED COMPOSITIONS OF INHALED NINTEDANIB AND NINTEDANIB SALTS - Disclosed herein are formulations of nintedanib and salts thereof, indolinone derivative compounds and salts thereof for aerosolization and use of such formulations for the prevention or treatment of various fibrotic, carcinogenic, vascular and viral infectious diseases, including diseases associated with the lung, heart, kidney, liver, eye, central nervous system and surgical sites. Formulations and delivery options described herein allow for efficacious local delivery of nintedanib or a indolinone derivative compound or salt thereof. Methods include inhalation procedures, indications and manufacturing processes for production and use of the compositions described. Also included are methods for identifying compounds and indications that benefit by reformulation and inhalation administration.2022-01-06
20220000773SELF-REMINDING PATCH - The inventive transdermal therapeutic systems (TTS) incorporate a timing device, such as an electronic timing device, particularly a thin, electronic timing device. The timing device can be a part of, adhered to, or used in lieu of the TTS backing layer. The device generally includes a pre-programmed or pre-designated timer, an activation and/or reset button to start or reset the timer and an indicator, such as a visual indicator, to alert the patient when the administration time period has lapsed.2022-01-06
20220000774SUPPOSITORY FORMULATIONS HAVING CANNABINOID - The invention relates to cannabinoid suppository formulations and methods associated therewith. Specifically, the invention relates to a rectal or a vaginal suppository formulation having a cannabinoid in combination with a moldable polymer.2022-01-06
20220000775SOL-GEL COMPOSITION - One aspect of the present disclosure relates to a sol-gel composition enabling reversible sol-gel transition and, more specifically, to a sol-gel composition of which the viscosity changes by external physical force so that reversible sol-gel transition is performed.2022-01-06
20220000776PARENTERAL DOSAGE FORM OF AMIODARONE - The present invention provides a parenteral dosage form consisting essentially of a solution filled in a container, the solution comprising amiodarone or its pharmaceutically acceptable salt and a sulfo-alkyl ether beta-cyclodextrin in an aqueous vehicle, wherein the solution has a pH in the range of about 2.4 to 3.9 and further wherein the dosage form is sterilized by subjecting the filled container to autoclaving.2022-01-06
20220000777LIPOSOMAL ENHANCED INTRA-PERITONEAL CHEMOTHERAPY - The invention described herein is directed to treating neoplasms by intraperitoneal administration of liposomal formulations of chemotherapeutic drugs. Methods of instilling liposomal formulations of taxane and platin chemotherapeutic agents into the peritoneal cavity of a subject to treat ovarian cancer or a primary peritoneal cancer are disclosed. 2022-01-06
20220000778LIPID NANOPARTICLE FORMULATIONS - The invention provides certain specific lipid nanoparticles comprising: (a) one or more nucleic acid molecules; (b) cholesterol; (c) DSPC; (d) PEG-C-DMA; and (e) a cationic lipid; and pharmaceutical compositions comprising the lipid nanoparticles. The lipid nanoparticles and pharmaceutical compositions are particularly useful for delivering a nucleic acid such as siRNA or mRNA to a patient (e.g. a human) or to a cell.2022-01-06
20220000779IMMUNOGENIC COMPOSITIONS - Nanoparticles encapsulating polysaccharide conjugates and compositions comprising same are provided. Particularly the nanoparticles are prepared using a microfluidic device.2022-01-06
20220000780NANODISCS FOR PREVENTING AND TREATING PATHOGEN INFECTIONS AND METHODS OF USE THEREOF - The invention provides compositions that contain pathogen-binding nanodiscs and methods of using such compositions to treat and prevent pathogen infections. The compositions include nanodiscs functionalized with receptors that bind a pathogen. Binding of a pathogen to the nanodiscs neutralizes the pathogen by interfering with one or more aspects of its reproductive cycle. The compositions and methods are useful for treating or preventing infections in the body and for disinfecting aqueous fluids that may contain pathogens.2022-01-06
20220000781METHOD OF ENCAPSULATING ACTIVE INGREDIENTS IN LIPOSOMES - A method for encapsulating active ingredients in liposomes having an active ingredient solution encapsulated with a bilayer composed of two monomolecular layers of amphiphilic compounds comprises: 2022-01-06
20220000782PREVENTION OF LOCAL TUMOR RECURRENCE FOLLOWING SURGERY USING SUSTAINEDAND/OR DELAYED RELEASE OF MEDICAMENTS CONTAINED IN MICRO-PARTICLES - Provided herein are methods and compositions for treatment of a patient having a wound resulting from surgical resection of a tumor mass. In some embodiments, the methods provided herein include administering to the entirety of the wound area a composition before the wound area is closed, the composition having a first plurality of micro-particles comprising PLGA and one or more cancer treatment drugs, and a second plurality of micro-particles comprising PLGA and one or more wound healing drugs; wherein the wound healing drugs are released for a first period of time and the cancer treatment drugs are released for a second period of time without an initial burst release.2022-01-06
20220000783PEDIATRIC DOSAGE FORMS, METHODS OF MAKING AND USING - Pediatric and modified release dosage forms of vitamin D compounds, and methods of making and using the dosage forms, are disclosed.2022-01-06
20220000784SPHERICAL BEADS FOR USE IN PRODUCING PHARMACEUTICALLY ACTIVE PELLETS - Improved spherical beads that may be used in producing pharmaceutically active pellets by depositing a pharmaceutically active agent on the surface of said spherical beads. The spherical beads includes a pharmaceutically acceptable carrier material, including: 2022-01-06
20220000785ACTIVE INGREDIENT CONTAINING STABILISED SOLID MEDICINAL FORMS AND METHODS FOR THE PRODUCTION THEREOF - The invention relates to solid medicinal forms containing at least one active ingredient and at least one pharmaceutically compatible, water soluble drying agent which is selected from the group consisting of trimagnesium dicitrate and/or calcium chloride, the solid medicinal form having a drying loss of at most 6% and a relative equilibrium moisture content of 25% or less. The invention also relates to solid medicinal forms containing a moisture-sensitive active ingredient and trimagnesium dicitrate.2022-01-06
20220000786PHARMACEUTICAL PREPARATION - Provided is a technique for suppressing the composition changes between pemafibrate, a salt thereof or a solvate thereof and (meth)acrylic acid-based polymers. A pharmaceutical preparation is provided by storing a pharmaceutical composition containing the following components (A) and (B) in a tight package: (A) pemafibrate, a salt thereof or a solvate thereof; and (B) a (meth)acrylic acid-based polymer.2022-01-06
20220000787DELAYED RELEASE PHARMACEUTICAL COMPOSITION OF PREDNISONE AND PREPARATION THEREOF - The present invention relates to a delayed-release pharmaceutical composition comprising an active ingredient prednisone and one or more pharmaceutical excipient(s). The invention further relates to a process for preparation of said pharmaceutical composition for oral administration, particularly a tablet, comprising prednisone with one or more pharmaceutically acceptable excipient(s), wherein the tablet is formulated using a coating technique which has a significant impact on drug release.2022-01-06
20220000788METHOD FOR DRY POWDER COATING CAPSULES - The present disclosure provides a process of producing a dry powder coated pharmaceutical capsule. The method includes preparing a dry powder film forming polymer coating composition to be coated onto an outer surface of the capsules, a size of the particulate coating powder being in a range from about 1 nm to about 500 μm. The capsules are placed into an interior of a rotatable housing and may be preheated. The dry powder coating composition is sprayed into the interior of the housing while the rotatable housing is rotating to produce a uniform coating of the dry powder coating composition on the outer surface of the capsules. The coated capsules are cured form a substantially uniform cured.2022-01-06
20220000789IMPLANTABLE DEVICES FOR CELL THERAPY AND RELATED METHODS - Described herein are implantable devices comprising means for mitigating the foreign body response (FBR) and at least one cell-containing compartment which comprises a plurality of cells (e.g., live cells) encapsulated in a polymer composition comprising a cell-binding substance (CBS), as well as compositions and methods of making and using the same. The cells are capable of expressing a therapeutic agent useful for the treatment of a disease, disorder, or condition described herein.2022-01-06
20220000790FORMULATION OF ACOUSTICALLY ACTIVATABLE PARTICLES HAVING LOW VAPORIZATION ENERGY AND METHODS FOR USING SAME - Acoustically activatable particles having low vaporization energy and methods for making and using same are disclosed. A particle of material includes a first substance that includes at least one component that is a gas 25° C. and atmospheric pressure. A second substance, different from the first substance, encapsulates the first substance to create a droplet or emulsion that is stable at room temperature and atmospheric pressure. At least some of the first substance exists in a gaseous phase at the time of encapsulation of the first substance within the second substance to form a bubble. After formation of the bubble, the bubble is condensed into a liquid phase, which causes the bubble to transform into the droplet or emulsion having a core consisting of a liquid. The droplet or emulsion is an activatable phase change agent that remains a droplet having a core consisting of a liquid at 25° C. and atmospheric pressure. The first substance has a boiling point below 25° C. at atmospheric pressure.2022-01-06
20220000791MULTI-LAYERED PARTICLES - Multi-layered particles and compositions comprising a compound are disclosed. Processes of preparing the particles and compositions and uses thereof are also disclosed.2022-01-06
20220000792ALBUMIN PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR - Disclosed herein is an albumin pharmaceutical composition, comprising albumin and at least one amino acid having a relative molecular mass of 145-175. Clinically, the albumin pharmaceutical composition can effectively reduce undesirable responses, such as rash, urticaria, anaphylaxis and possible immune responses in the human body caused by albumin polymers and dimers, thereby further ensuring the safety in clinical medication2022-01-06
20220000793BIOMASS-BASED ENCAPSULATING MATERIAL FOR PROTECTION OF PROBIOTIC ACTIVITY AND AN ENCAPSULATING METHOD - A biomass-based encapsulating material for protection of probiotic activity and an encapsulating method are disclosed. The biomass-based encapsulating material includes a nano-film having two layers for encapsulating probiotics. A first layer is formed through natural biological macromolecules and metal ions on surfaces of the probiotics by covalent cross-linking or metal chelating action in situ, and a second layer is formed by interactions between a bio-enzyme and the natural biological macromolecules. The nano-film formed in situ on cell walls of probiotics is used for encapsulation and protection of probiotics. The nano-film is made of natural biomass, has low cost and has no toxic side effects. The relative activity of encapsulated probiotics is close to or higher than 90%, whether they are cultivated in environments under high concentration of antibiotics or active-free radicals. The relative activity of unprotected probiotics is below 30%, or even completely unable to survive.2022-01-06
20220000794TRANSDERMAL PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS - The present disclosure relates to the to the transdermal administration of THC and/or CBD and derivatives of these compounds, for the treatment and/or prevention and/or control of multiple sclerosis, multiple sclerosis-related muscle spasms, and pain and/or spasticity in multiple sclerosis.2022-01-06
20220000795Water Soluble Cannabinoid Product with Reduced Particle Size for Enhanced Delivery - An aqueous cannabinoid product including surfactant, preservative, acidulant, and cosurfactant. Most commonly cannabidiol is the cannabinoid product in the aqueous product. The cosurfactant used is typically a phytochemical product which reduces the particle size of the aqueous cannabinoid emulsion.2022-01-06
20220000796COMPOSITIONS COMPRISING CBD FOR TREATING ANORECTAL DISORDERS - The present invention discloses compositions comprising CBD and several herbal extracts and powders, and methods for the treatment of anorectal disorders such as hemorrhoids. In particular, the invention provides compositions useful in the treatment and alleviation of hemorrhoids and related symptoms2022-01-06
20220000797CLEAR PROPOFOL INJECTION AND PREPARATION METHOD THEREFOR - Disclosed are a clear propofol injection and a preparation method therefor, wherein the injection comprises the following components: propofol, cyclodextrin, stabilizer, pH regulator, and water for injection, and the pH value of the injection is 6-9, preferably 7-8.5.2022-01-06
20220000798TRANS-RESVERATROL TOPICAL MEDICATION FOR THE TREATMENT OF PAIN AND METHOD OF MANUFACTURE THEREOF - The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (2022-01-06
20220000799SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF - This application describes modified amino acids and polypeptides comprising a SO2022-01-06
20220000800USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY - The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; Aicardi syndrome; CDKL5 and Dup15q in comparison to other seizure types. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).2022-01-06
Website © 2025 Advameg, Inc.